Diamedica Therapeutics Stock Price on March 10, 2021

DMAC Stock  USD 2.77  0.12  4.53%   
Below is the normalized historical share price chart for DiaMedica Therapeutics extending back to January 04, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of DiaMedica Therapeutics stands at 2.77, as last reported on the 28th of March, with the highest price reaching 2.81 and the lowest price hitting 2.73 during the day.
IPO Date
4th of January 2008
200 Day MA
2.9319
50 Day MA
2.9072
Beta
1.711
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
If you're considering investing in DiaMedica Stock, it is important to understand the factors that can impact its price. We consider DiaMedica Therapeutics moderately volatile. DiaMedica Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0024, which denotes the company had a 0.0024% return per unit of standard deviation over the last 3 months. We have found twenty-two technical indicators for DiaMedica Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm DiaMedica Therapeutics' Coefficient Of Variation of (6,026), standard deviation of 3.01, and Mean Deviation of 2.23 to check if the risk estimate we provide is consistent with the expected return of 0.0075%.
  
At present, DiaMedica Therapeutics' Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 56.9 M, whereas Stock Based Compensation is forecasted to decline to about 876.3 K. . As of March 28, 2024, Price Earnings Ratio is expected to decline to -5.01. In addition to that, Price To Sales Ratio is expected to decline to 49.24. DiaMedica Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0024

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsDMAC

Estimated Market Risk

 3.12
  actual daily
27
73% of assets are more volatile

Expected Return

 0.01
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average DiaMedica Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DiaMedica Therapeutics by adding DiaMedica Therapeutics to a well-diversified portfolio.
Price Book
2.0222
Book Value
1.345
Enterprise Value
50.8 M
Enterprise Value Ebitda
(2.39)
Shares Float
23.8 M

DiaMedica Therapeutics Valuation on March 10, 2021

It is possible to determine the worth of DiaMedica Therapeutics on a given historical date. On March 10, 2021 DiaMedica was worth 2.45 at the beginning of the trading date compared to the closed value of 2.31. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of DiaMedica Therapeutics stock. Still, in general, we apply an absolute valuation method to find DiaMedica Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of DiaMedica Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against DiaMedica Therapeutics' related companies.
 Open High Low Close Volume
03/14/2022
  2.45    2.52    2.26    2.31    40,800  
  2.26    2.49    2.20    2.30    26,500  
Backtest DiaMedica Therapeutics  |  DiaMedica Therapeutics History  |  DiaMedica Therapeutics Valuation Next  
Open Value
2.45
2.31
Closing Value
11.82
Upside

DiaMedica Therapeutics Trading Date Momentum on March 10, 2021

The event impact on price volatility cannot be determined at this time. Please check this event after some time to allow current data to be analyzed.

DiaMedica Therapeutics Fundamentals Correlations and Trends

By evaluating DiaMedica Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among DiaMedica Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. DiaMedica financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About DiaMedica Therapeutics Stock history

DiaMedica Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for DiaMedica is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in DiaMedica Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing DiaMedica Therapeutics stock prices may prove useful in developing a viable investing in DiaMedica Therapeutics
Last ReportedProjected for 2024
Common Stock Shares Outstanding32.6 M34.2 M
Net Loss-12.2 M-11.6 M

DiaMedica Therapeutics Quarterly Net Working Capital

50.89 Million

DiaMedica Therapeutics Stock Technical Analysis

DiaMedica Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of DiaMedica Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of DiaMedica Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

DiaMedica Therapeutics Period Price Range

Low
March 14, 2022
High

 2.45 

  

 2.31 

-0.14-5.71%

DiaMedica Therapeutics March 28, 2024 Market Strength

Market strength indicators help investors to evaluate how DiaMedica Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DiaMedica Therapeutics shares will generate the highest return on investment. By undertsting and applying DiaMedica Therapeutics stock market strength indicators, traders can identify DiaMedica Therapeutics entry and exit signals to maximize returns

DiaMedica Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for DiaMedica Therapeutics' price direction in advance. Along with the technical and fundamental analysis of DiaMedica Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of DiaMedica to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether DiaMedica Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DiaMedica Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Diamedica Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Diamedica Therapeutics Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DiaMedica Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation.
For information on how to trade DiaMedica Stock refer to our How to Trade DiaMedica Stock guide.
Note that the DiaMedica Therapeutics information on this page should be used as a complementary analysis to other DiaMedica Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Complementary Tools for DiaMedica Stock analysis

When running DiaMedica Therapeutics' price analysis, check to measure DiaMedica Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DiaMedica Therapeutics is operating at the current time. Most of DiaMedica Therapeutics' value examination focuses on studying past and present price action to predict the probability of DiaMedica Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DiaMedica Therapeutics' price. Additionally, you may evaluate how the addition of DiaMedica Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Is DiaMedica Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DiaMedica Therapeutics. If investors know DiaMedica will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DiaMedica Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.60)
Return On Assets
(0.30)
Return On Equity
(0.47)
The market value of DiaMedica Therapeutics is measured differently than its book value, which is the value of DiaMedica that is recorded on the company's balance sheet. Investors also form their own opinion of DiaMedica Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is DiaMedica Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DiaMedica Therapeutics' market value can be influenced by many factors that don't directly affect DiaMedica Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DiaMedica Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if DiaMedica Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DiaMedica Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.